Back to search
Advanced Systemic Mastocytosis (AdvSM)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced Systemic Mastocytosis (AdvSM) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Advanced Systemic Mastocytosis (AdvSM) trials you may qualify forThis is an open-label, two-part Phase 2 study investigating CGT9486 for the treatment of patients with Advanced Systemic Mastocytosis (AdvSM), including patient…
The primary objective of the rollover study is to evaluate the long-term safety of avapritinib in participants who have completed a Blueprint Medicines sponsore…
The goal of this clinical trial is to evaluate elenestinib (BLU-263) in participants with Advanced Systemic Mastocytosis (AdvSM), SM with an associated hematolo…
This is a Phase 1, open-label, dose-escalation study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antineoplas…